MENU
APLS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Apellis Pharmaceuticals (APLS) Ownership - Who owns Apellis Pharmaceuticals?
Industry: @Medical Distributors
Profile
Industry
Medical Distributors
Address
100 Fifth Avenue
Phone
+1 617 977-5700
Employees
706
Web
https://www.apellis.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
4.14B
P/E Ratio
N/A
Total Cash
396.86M
Projected Growth
N/A
Total Debt
470.45M
Revenue
715.22M
Risk (Beta)
-0.04
Dividend Yield
N/A
Total Cash/Share
3.19
Total Debt/Equity
N/A
Revenue/Share
5.81 USD as % of share price
Fundamentals
APLS
Capitalization
4.15B
P/E Ratio
N/A
Risk (Beta)
-0.04
Dividend Yield
N/A
Total Cash
397M
Total Cash/Share
3.19
Total Debt
470M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
5.81%
Revenue
715M
ROE
N/A
Book Value
237M
P/B Ratio
17.48
Cash Flow
N/A
Earnings
-2.03
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
12K
Current Ratio
4.36
Current Revenue Per Employee
280384.62
Dividends Per Share - Security
N/A
EBITDA
-209.71M
Float
N/A
Float - Current
N/A
Gross Income Margin
82.95
Revenue To Assets
-29.08
Shares Held By Institutions
7.38B
Shares Outstanding - Current
124M
Total Liabilities
665M
Total Volume MTD
N/A
Value
-1
Gain YTD
-44.337
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of therapeutics and drug delivery technologies to address chronic inflammatory diseases
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Medical Distributors
Address
100 Fifth Avenue
Phone
+1 617 977-5700
Employees
706
Web
https://www.apellis.com